Navigation Links
Merck & Co., Inc. Named Keynote Sponsor For Diversity Alliance For Science's Inaugural Conference
Date:3/28/2008

Global Pharmaceutical Company Supports Organization's National Networking

And Expo Event

MORRISTOWN, N.J., March 28 /PRNewswire/ -- Diversity Alliance for Science, Inc. (DA4S) (http://www.diversityallianceforscience.com) has announced that Merck & Co., Inc. will serve as the keynote sponsor for its inaugural networking conference and expo scheduled for May 19-20 at the Westin Governors in Morristown, N.J. The two-day event will focus on developing and integrating more minority, women, veteran and disabled-owned businesses into the life sciences space. The national event is expected to draw top-level pharmaceutical executives, high-ranking government officials and CEOs of diverse scientific and clinical enterprises.

Merck & Co, Inc. is one of the largest pharmaceutical companies in the world. Established in 1891 and headquartered in Whitehouse Station, N.J., the company discovers, develops, manufactures and markets a broad range of products aimed at improving human and animal health. Merck has 59,800-plus employees worldwide and products sold in more than 140 countries. The company boasts a Manufacturing Division, which employs more than 12,000 people at locations in 25 countries, as well as The Merck Research Laboratories, which employs approximately 9,500 people at sites in the U.S., Canada, Europe and Asia. Through The Merck Foundation, founded in 1957, the company has distributed more than $480 million to educational and nonprofit organizations worldwide.

"Merck's success has been built from the diversity of its employees and from a diverse customer base," said Sally Macaluso, senior director of global procurement for Merck & Co., Inc. "One of Merck's key corporate objectives is to grow supplier diversity spend to support the diverse communities in which we do business. As such, Merck is a proud sponsor of Diversity Alliance For Science's 'Diversity Creates Scientific Innovation Conference and Expo.'"

About Diversity Alliance for Science, Inc. (DA4S):

Diversity Alliance for Science, Inc. (DA4S) is a nonprofit organization aimed to provide pharmaceutical/bio-tech companies, academic medical centers and governmental agencies the ability to identify, develop, mentor and partner with woman, minority, veteran and disabled-owned enterprises (both large and small) in the life sciences industry. For more information, please visit http://www.diversityallianceforscience.com.

Patty Briguglio

MMI Associates, Inc.

(919) 233-6600

patty@mmimarketing.com

PR Firms Raleigh, NC


'/>"/>
SOURCE Diversity Alliance for Science, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates
2. ZymoGenetics and Merck Serono Receive FDA Special Protocol Assessment for Atacicept Pivotal Study in Lupus Nephritis
3. Merck Will Obtain Blockbuster Antidiabetic Drug Sales in Type 2 Diabetes Market by 2011
4. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
5. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck & Co., Inc.
6. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
7. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
8. Miaxis Biometrics Named as Red Herring 100 Asia Award Winner for 2007
9. Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
10. Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist
11. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
(Date:6/23/2016)... ... 2016 , ... Supplyframe, the Industry Network for electronics hardware ... . Located in Pasadena, Calif., the Design Lab’s mission is to bring together ... built and brought to market. , The Design Lab is Supplyframe’s physical representation ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
Breaking Biology Technology:
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
(Date:6/1/2016)... YORK , June 1, 2016 ... Technology in Election Administration and Criminal Identification to Boost ... to a recently released TechSci Research report, " Global ... By Region, Competition Forecast and Opportunities, 2011 - 2021", ... 24.8 billion by 2021, on account of growing security ...
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
Breaking Biology News(10 mins):